首页> 美国卫生研究院文献>Journal of Surgical Case Reports >Highly aggressive undifferentiated small round blue cell tumor of foot with unique SMARCA1 KAT6A and NAV3 mutations
【2h】

Highly aggressive undifferentiated small round blue cell tumor of foot with unique SMARCA1 KAT6A and NAV3 mutations

机译:足部高度侵袭性未分化小圆形蓝细胞肿瘤具有独特的SMARCA1KAT6A和NAV3突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Malignancies characterized histologically by high-grade monotonous small round blue cells (SRBCs) belong to a heterogeneous group of neoplasms often referred to as Ewing family of tumors. The most common molecular confirmation of these neoplasms is by fusions between EWSR1 gene on chromosome 22 and the ETS family of transcription factors, including FLI1 gene (11q24) and the ERG (21q22), that are implicated in the development of different tissues as well as cancer progression. In this article, we present a case of highly aggressive extraskeletal SRBC tumor involving the foot of a 24-year-old male with sole molecular findings of mutations in KAT6A, NAV3 and SMARCA1 genes with high expression of soft tissue markers (COL1A1, COL1A2, COL3A1) and MYC mRNA. To our knowledge, this unique mutational pattern has not previously been described in SRBCs.
机译:在组织学上以高级单调小圆形蓝细胞(SRBC)为特征的恶性肿瘤属于异质性肿瘤组,通常被称为尤因家族肿瘤。这些肿瘤最常见的分子确证是通过22号染色体上的EWSR1基因与ETS转录因子家族的融合,包括FLI1基因(11q24)和ERG(21q22),这牵涉到不同组织的发育以及癌症进展。在本文中,我们介绍了一例高度侵袭性的骨骼外SRBC肿瘤,涉及一名24岁男性的足部,唯一分子发现了KAT6A,NAV3和SMARCA1基因的突变,这些基因在软组织标志物(COL1A1,COL1A2, COL3A1)和MYC mRNA。据我们所知,这种独特的突变模式以前并未在SRBC中得到描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号